Background: Oxidants including reactive oxygen species have been indicated to play an important role in the pathogenesis of asthma. Objective: We investigated oxidative status in patients with acute exacerbations of asthma and evaluated the therapeutic response using the D-ROM test which is simple to use and quick. Methods: We measured reactive oxygen metabolite (ROM) levels in the serum of 42 outpatients with acute exacerbations of asthma, 11 outpatients with stable asthma and 40 healthy subjects using the D-ROM test. Seven inpatients admitted due to acute exacerbations of asthma were also enrolled to evaluate the effects of treatment. Serum eosinophil cationic protein and plasma polymorphonuclear elastase were also measured by EIA or ELISA to evaluate the correlation between inflammation and oxidative status. Results: Serum ROM levels were significantly higher in patients with acute exacerbation of asthma than in patients with stable asthma or healthy subjects. Levels of serum eosinophil cationic protein and plasma polymorphonuclear elastase were increased in acute exacerbation and moderately correlated to ROM levels. Levels of ROM were significantly decreased after treatment with systemic steroids and bronchodilators. Conclusion: These findings suggest that acute exacerbation of asthma is associated with increased oxidative stress. Serum ROM levels would partly reflect the inflammation with eosinophils and neutrophils and may be useful as biomarkers of asthma.

Keywords:
Asthma, Free radical, Oxidative stress, Reactive oxygen metabolite
1.
Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM: Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720–1745.
2.
Barnes PJ: New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989;83:1013–1026.
3.
Barnes PJ: Reactive oxygen species and airway inflammation. Free Radic Biol Med 1990;9:235–243.
4.
Bowler RP: Oxidative stress in the pathogenesis of asthma. Curr Allergy Asthma Rep 2004;4:116–122.
5.
Kirkham P, Rahman I: Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006;111:476–494.
6.
Mak JC, Chan-Yeung MM: Reactive oxidant species in asthma. Curr Opin Pulm Med 2006;12:7–11.
7.
Andreadis AA, Hazen SL, Comhair SA, Erzurum SC: Oxidative and nitrosative events in asthma. Free Radic Biol Med 2003;35:213–225.
8.
MacPherson JC, Comhair SA, Erzurum SC, Klein DF, Lipscomb MF, Kavuru MS, Samoszuk MK, Hazen SL: Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 2001;166:5763–5772.
9.
Evans DJ, Lindsay MA, O’Connor BJ, Barnes PJ: Priming of circulating human eosinophils following late response to allergen challenge. Eur Respir J 1996;9:703–708.
10.
Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A: Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393–397.
11.
Vachier I, Chanez P, Doucen CL, Damon M, Descomps B, Godard P: Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients. Eur Respir J 1994;7:1585–1592.
12.
Loukides S, Bouros D, Papatheodorou G, Panagou P, Siafakas NM: The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest 2002;121:338–346.
13.
Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ: Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999;160:216–220.
14.
Kharitonov SA, Barnes PJ: Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001;163:1693–1722.
15.
Nadeem A, Raj HG, Chhabra SK: Increased oxidative stress in acute exacerbations of asthma. J Asthma 2005;42:45–50.
16.
Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. Bethesda, National Institutes of Health, National Heart Lung and Blood Institute, 2003.
17.
Cesarone MR, Belcaro G, Carratelli M, Cornelli U, Sanctis MTD, Incandela L, Barsotti A, Terranova R, Nicolaides A: A simple test to monitor oxidative stress. Int Angiol 1999;18:127–130.
18.
Cornelli U, Terranova R, Luca S, Cornelli M, Alberti A: Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr 2001;131:3208–3211.
19.
Panyutich AV, Hiemstra PS, van Wetering S, Ganz T: Human neutrophil defensin and serpins form complexes and inactivate each other. Am J Respir Cell Mol Biol 1995;12:351–357.
20.
Nadeem A, Chhabra SK, Masood A, Raj HG: Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol 2003;111:72–78.
21.
Comhair SA, Ricci KS, Arroliga M, Lara AR, Dweik RA, Song W, Hazen SL, Bleecker ER, Busse WW, Chung KF, Gaston B, Hastie A, Hew M, Jarjour N, Moore W, Peters S, Teague WG, Wenzel SE, Erzurum SC: Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. Am J Respir Crit Care Med 2005;172:306–313.
22.
Battaglia S, den Hertog H, Timmers MC, Lazeroms SP, Vignola AM, Rabe KF, Bellia V, Hiemstra PS, Sterk PJ: Small airways function and molecular markers in exhaled air in mild asthma. Thorax 2005;60:639–644.
23.
Ercan H, Birben E, Dizdar EA, Keskin O, Karaaslan C, Soyer OU, Dut R, Sackesen C, Besler T, Kalayci O: Oxidative stress and genetic and epidemiologic determinants of oxidant injury in childhood asthma. J Allergy Clin Immunol 2006;118:1097–1104.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.